Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
HOME > TOP STORIES
TOP STORIES
-
BUSINESS AstraZeneca Looks to Keep No.1 Spot in Japan Oncology Space, Driven by Bispecific Antibodies
February 7, 2025
-
BUSINESS Celltrion Set for 6 Biosimilar Filings in 2 Years, Sees Japanese Data Waiver as a Boon
February 6, 2025
-
REGULATORY Japan’s 1st Hemophilia B Gene Therapy Up for Panel Review on Feb. 19
February 6, 2025
-
COMMENTARY Companies Welcome Generic Drug Fund, but Fret Pricing and Regulations
February 5, 2025
-
BUSINESS Astellas to Revamp Management in April, Consolidate R&D Functions
February 5, 2025
-
ACADEMIA Medical Society Says “No” to Discontinuation of Theodur Despite Supply Struggle
February 5, 2025
-
REGULATORY PMD Act Set for Amendments Covering Issues Unaddressed over Past Decade: MHLW Official
February 4, 2025
-
BUSINESS Daiichi Sankyo Assigns COO Okuzawa as CEO from April
February 3, 2025
-
BUSINESS Julie Kim Tapped to Take Over Helm of Takeda in 2026
January 31, 2025
-
BUSINESS Takeda CEO Weber to Retire Next Year, Succeeded by US Head
January 30, 2025
-
BUSINESS Pfizer Japan Resolved to Drive Vaccine Demand, New Drug Launches: President
January 30, 2025
-
REGULATORY Pfizer’s Litfulo Braced for Price Cut after Cost-Effectiveness Assessment
January 30, 2025
-
REGULATORY MHLW Panel Finalizes NIP Inclusion of Shingles Jabs, OKs New Basic Immunization Plan
January 30, 2025
-
BUSINESS Nichi-Iko to Start Production Collaboration with Kyowa in FY2025: President
January 29, 2025
-
REGULATORY LDP-OK’ed Bill for PMD Act Amendment Specifies Launch of Innovative Drug Fund
January 28, 2025
-
BUSINESS Sanofi Stages V-Shaped Recovery in Vaccine Biz, Set for Growth with New Products Beyond Hib
January 27, 2025
-
BUSINESS MHLW Planning 10-Year Fund for Drug Discovery, Official Reveals at JPMA Meeting
January 24, 2025
-
REGULATORY MHLW Eyes 2 Biz Models as It Pushes Generic Industry Shakeup: Minister
January 23, 2025
-
BUSINESS Sanofi CEO Warns Off-Cycle Price Cuts Will Dilute Attractiveness of Japan Market
January 22, 2025
-
REGULATORY Astellas’ Xtandi on 2nd Drug List Up for IRA Price Negotiations
January 21, 2025
ページ
As Japan approaches the Fiscal System Council’s “autumn recommendation,” a notable shift is taking shape. The Ministry of Finance (MOF),…
Japan is considering a new approach to its “special” market expansion re-pricing that would exclude drug sales tied to private…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…